Health Care & Life Sciences » Pharmaceuticals | Formosa Laboratories Inc.

Formosa Laboratories Inc. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
413
405
419
347
619
878
Total Accounts Receivable
818
713
942
887
849
896
Inventories
679
957
1,113
932
913
1,290
Other Current Assets
63
60
90
76
99
165
Total Current Assets
1,974
2,136
2,563
2,243
2,480
3,228
Net Property, Plant & Equipment
2,678
2,930
3,027
2,907
3,608
4,224
Total Investments and Advances
274
556
788
1,133
742
830
Intangible Assets
9
17
22
24
343
351
Other Assets
25
23
16
379
7
10
Total Assets
4,991
5,690
6,456
6,734
7,242
8,725
ST Debt & Current Portion LT Debt
1,225
973
1,309
1,184
1,563
Accounts Payable
174
118
182
197
163
Income Tax Payable
15
40
55
97
34
Other Current Liabilities
358
337
347
453
524
Total Current Liabilities
1,772
1,469
1,893
1,931
2,284
Long-Term Debt
676
1,180
1,095
686
583
Provision for Risks & Charges
-
11
8
11
12
Deferred Taxes
15
9
22
31
29
Other Liabilities
-
11
-
-
170
Total Liabilities
2,475
2,681
3,013
2,646
3,141
Common Equity (Total)
2,516
3,009
3,443
4,089
4,019
Total Shareholders' Equity
2,516
3,009
3,443
4,089
4,019
Total Equity
2,516
3,009
3,443
4,089
4,101
Liabilities & Shareholders' Equity
4,991
5,690
6,456
6,734
7,242
Accumulated Minority Interest
-
-
-
-
81

About Formosa Laboratories

View Profile
Address
No. 36 Hoping Street
Taoyuan 338 42
Taiwan
Employees -
Website http://www.formosalab.com
Updated 07/08/2019
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. It specializes in development, production, process, and sale of ultraviolet absorbers, cholesterol phosphate binders, vitamin D derivatives, anti-inflammatory analgesic, and central nervous system drugs. The company's products include active pharmaceutical ingredients, contract research and custom synthesis, integrated application delivery controller services, and ultraviolet filters for sunscreens and cosmetics.